Japan Market Approval On Track For All-Case Surveillance Drugs From Lilly, GSK, Otsuka
This article was originally published in PharmAsia News
Executive Summary
TOKYO - A string of drugs are on track for marketing approval in Japan, as the pharmaceutical subcommittee of the Pharmaceutical Affairs and Food Sanitation Council confirmed its consent for approval of 22 new drugs and additional indications